Detalles de la búsqueda
1.
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma.
Support Care Cancer
; 20(3): 647-52, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22101611
2.
Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
Clin Lymphoma Myeloma Leuk
; 12(5): 297-305, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23040435
3.
The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice.
Leuk Res
; 36(5): 548-53, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22385870
4.
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.
Hematology
; 13(4): 195-202, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18796244
5.
Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice.
Leuk Lymphoma
; 53(5): 982-4, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22111969
Resultados
1 -
5
de 5
1
Próxima >
>>